Spondylodiscitis caused by Mycobacterium xenopi

Archives of Orthopaedic and Trauma Surgery

Volumn 128, Issue 10, 2008, Pages 1047-1053

  Sobottke, R ^a   Zarghooni, K ^a   Seifert, H ^a   Faetkenheuer, G ^a   Koriller, M ^a   Michael, J W P ^a   Delank, K S ^a   Eysel, P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

HIV; Immunodeficiency; Mycobacterium xenopi; Spondylitis; Spondylodiscitis

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; FLUORODEOXYGLUCOSE F 18; ISONIAZID; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; PYRIDOXINE; RIFABUTIN; TUBERCULOSTATIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; ARTICLE; BACKACHE; BIOPSY TECHNIQUE; CASE REPORT; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; EPIDURAL ABSCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMAGE ANALYSIS; INTERVERTEBRAL DISK DEGENERATION; KINESIOTHERAPY; LABORATORY TEST; LUNG INFECTION; MYCOBACTERIUM XENOPEI; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAIN ASSESSMENT; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SPINE STABILIZATION; SURGICAL DRAINAGE; THORACOTOMY; TREATMENT RESPONSE;

ADULT; DISCITIS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM XENOPI;

EID: 53149095849     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-007-0553-y     Document Type: Article

References (31)

1. Meybeck A, Fortin C, Abgrall S, Adle-Biassette H, Hayem G, Ruimy R, Yeni P (2005) Spondylitis due to Mycobacterium xenopi in a Human Immunodeficiency Virus Type 1-infected patient: Case report and review of the literature. J Clin Microbiol 43(3):1465-1466
2. Danesh-Clough T, Theis JC, Linden A (2000) Mycobacterium xenopi infection of the spine. Spine 1;25(5):626-628
3. Manfredi R, Nanetti A, Morelli S, Ferri M, Valentini R, Calza L, Chiodo F (2004) A decade surveillance study of Mycobacterium xenopi and antimicrobial susceptibility levels in a reference teaching hospital of Northern Italy: HIV-associated versus non-HIV-associated infection. HIV Clin Trials 5(4):206-215
4. Kulasegaram R, Richardson D, Macrae B, Ruiter A (2001) Mycobacterium xenopi osteomyelitis in a patient on highly active antiretroviral therapy (HAART). Int J STD AIDS 12:404-406
5. Bossert T, Bittner HB, Richter M, Rahmel A, Barten M, Gummert J, Mohr FW (2005) Successful management of two heart transplant recipients with mycobacterial pulmonary infections. Ann Thorac Surg 80(2):719-721
6. Telgt DS, van den Hoogen FH, Meis JF, Lemmens JA, van de Putte LB (1997) Arthritis and spondylodiscitis caused by Mycobacterium xenopi in a patient with systemic lupus erythematosus. Br J Rheumatol 36(9):1025-1026
7. American Thoracic Society (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:1-25
8. Schmitt H, Schnitzler N, Riehl J, Adam G, Sieberth HG, Haase G (1999) Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with Clarithromycin, Rifabutin and Sparfloxacin. Clin Infect Dis 29(1):120-124
9. Bachmeyer C, Blum L, Stelianides S, Benchaa B, Gruat N, Danne O (2001) Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment. Thorax 56:978-979
10. Miller WC, Perkins MD, Richardson WJ, Sexton DJ (1994) Pott's disease caused by Mycobacterium xenopi: Case report and review. Clin Infect Dis 19(6):1024-1028
11. Ollagnier E, Fresard A, Guglielminotti C, Carricajo A, Mosnier JF, Alexandre C, Lucht F (1998) Osteoarticular Mycobacterium xenopi infection. Presse Med 27(17):800-803
12. Jones PG, Schrager MA, Zabransky RJ (1995) Pott's disease caused by Mycobacterium xenopi. Clin Infect Dis 21(5):1352
13. Astegneau P, Desplaces N, Vincent V, Chicheportiche V, Botherel A, Maugat S, Lebascle K, Leonard P, Desenclos J, Grosset J, Ziza J, Brucker G (2001) Mycobacterium xenopi spinal infections after discovertebral surgery: Investigation and screening of a large outbreak. Lancet 1;358(9283):747-751
14. Kerbiriou L, Ustianowski A, Jonson MA, Gillespie SH, Miller RF, Lipman CI (2003) Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: A need to treat? Clin Infect Dis 1;37(9):1250-1254
15. Schwabacher H (1959) A strain of mycobacterium isolated from skin lesions of a cold blooded animal, Xenopus laevis, and its relation to acid fast bacilli occuring in man. J Hyg 44:378-380
16. Marks J, Schwabacher H (1965) Infection due to Mycobacterium xenopi. BMJ 1:32-33
17. Juffermans NP, Verbon A, Danner SA, Kuijper EJ, Speelman P (1998) Mycobacterium xenopi in HIV-infected patients: An emerging pathogen. AIDS 12:1661-1666
18. El-Helou P, Rachlis A, Fong I (1997) Mycobacterium xenopi infections in patients with human immunodeficiency virus infection. Clin Infect Dis 25:206-210
19. Prosser AJ (1986) Spinal infection with Mycobacterium xenopi. Tubercle 67:229-232
20. Rahman MA, Phongsathom V, Hughes T, Bielawska C (1992) Spinal infection by Mycobacterium xenopi in a non-immunosuppressed patient. Tuber Lung Dis 73:392-395
21. Arasteh KN, Cordes C, Ewers M (2000) HIV related NTM infection: incidence, survival analysis and associated risk factors. Eur J Med Res 5:424-430
22. Moon M, Woo Y, Lee K, Ha K, Kim S, Sun D (1995) Posterior instrumentation and anterior interbody fusion for tuberculous kyphosis of dorsal and lumbar spines. Spine 20:1910-1916
23. Oga M, Arizono T, Takasita M, Sugioka Y (1993) Evaluation of the risk of instrumentation as a foreign body in spinal tuberculosis. Spine 18:1890-1894
24. Costrini AM, Manler DA, Gross WM, Hawkins VE, Yesner R, D'Esporo ND (1981) Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis 123:104-109
25. Hoffner SE (1994) Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria. Eur J Clin Microbiol Infect Dis 13:937-941
26. Research Committee of the British Thoracic Society (2001) First randomised trial of treatments for pulmonary disease caused by M. avium intracellulare, M. malmoense, and M. xenopi in HIV negative patients: rifampicin, ethambutol, and isoniazid versus rifampicin and ethambutol. Thorax 56:167-172
27. Banks J, Hunter AM, Campbell IA (1984) Pulmonary infection with Mycobacterium xenopi: Review of treatment and response. Thorax 39:376-382
28. Griffith DE, Wallace RJ (1996) New developments in the treatment of nontuberculous mycobacterial disease. Semin Respir Iinfect 11:301-310
29. Alangaden GJ, Lerner SA (1997) The clinical use fluoroquinolones for the treatment of mycobacterial diseases. Clin Infect Dis 25:1213-1221
30. Stumpe KD, Zanetti M, Weishaupt D, Hodler J, Boos N, von Schulthess GK (2002) FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR 179:1151-1157
31. Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O (2001) Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: Preliminary results. Eur Spine J 10:534-539